Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-04-10 06:00 am Sale |
2025-03-31 | 13G | Conduit Pharmaceuticals Inc. CDT |
ASTRAZENECA PLC | 73,892 1.100% |
-21,153 (-22.26%) |
Filing History |
| 2025-02-20 4:32 pm Sale |
2025-02-19 | 13G | Conduit Pharmaceuticals Inc. CDT |
Nirland Limited | 0 0.000% |
-153,500 (Position Closed) |
Filing History |
| 2025-01-21 5:00 pm Purchase |
2025-01-13 | 13G | Conduit Pharmaceuticals Inc. CDT |
Nirland Limited | 153,500 9.979% |
133,500 (+667.50%) |
Filing History |
| 2024-11-06 06:01 am Sale |
2024-09-03 | 13G | Conduit Pharmaceuticals Inc. CDT |
St George Street Capital | 0 0.000% |
-47,498 (Position Closed) |
Filing History |
| 2024-10-18 4:15 pm Sale |
2024-10-11 | 13G | Conduit Pharmaceuticals Inc. CDT |
Nirland Limited | 20,000 2.000% |
-60,920 (-75.28%) |
Filing History |
| 2024-10-11 06:01 am Purchase |
2024-08-07 | 13G | Conduit Pharmaceuticals Inc. CDT |
ASTRAZENECA PLC | 95,045 9.900% |
95,045 (New Position) |
Filing History |
| 2024-10-07 7:36 pm Sale |
2024-10-04 | 13G | Conduit Pharmaceuticals Inc. CDT |
Nirland Limited | 80,920 8.300% |
-64,080 (-44.19%) |
Filing History |
| 2024-09-19 4:59 pm Sale |
2024-03-26 | 13D | Conduit Pharmaceuticals Inc. CDT |
Corvus Capital Ltd. | 302,927 31.560% |
-153,011 (-33.56%) |
Filing History |
| 2024-08-13 4:29 pm Purchase |
2024-08-06 | 13G | Conduit Pharmaceuticals Inc. CDT |
Nirland Limited | 145,000 14.800% |
79,797 (+122.38%) |
Filing History |
| 2024-02-12 12:51 pm Purchase |
2023-12-31 | 13G | Conduit Pharmaceuticals Inc. CDT |
Polar Asset Management Partners Inc. | 9,500 1.300% |
9,500 (New Position) |
Filing History |
| 2024-02-08 1:15 pm Unchanged |
2023-12-31 | 13G | Conduit Pharmaceuticals Inc. CDT |
Saba Capital Management, L.P. | 0 0.000% |
0 (Unchanged) |
Filing History |
| 2024-02-02 4:28 pm Purchase |
2023-12-31 | 13G | Conduit Pharmaceuticals Inc. CDT |
Hudson Bay Capital Management LP | 731 0.100% |
731 (New Position) |
Filing History |
| 2023-10-02 4:30 pm Purchase |
2023-09-22 | 13G | Conduit Pharmaceuticals Inc. CDT |
Nirland Limited | 65,203 8.800% |
65,203 (New Position) |
Filing History |
| 2023-09-29 4:30 pm Purchase |
2023-09-22 | 13D | Conduit Pharmaceuticals Inc. CDT |
Corvus Capital Ltd. | 455,938 62.960% |
455,938 (New Position) |
Filing History |
| 2023-09-29 4:30 pm Purchase |
2023-09-22 | 13D | Conduit Pharmaceuticals Inc. CDT |
Murphy Canyon Acquisition Sponsor LLC | 47,243 6.500% |
47,243 (New Position) |
Filing History |
| 2023-09-29 4:30 pm Purchase |
2023-09-22 | 13G | Conduit Pharmaceuticals Inc. CDT |
St George Street Capital | 47,498 6.600% |
47,498 (New Position) |
Filing History |
| 2023-02-16 5:28 pm Purchase |
2022-02-13 | 13D | Murphy Canyon Acquisition Corp. MURF |
Shaolin Capital Management LLC | 609,750 20.730% |
609,750 (New Position) |
Filing History |
| 2023-02-14 12:08 pm Purchase |
2022-12-31 | 13G | Murphy Canyon Acquisition Corp. MURF |
MMCAP International Inc. SPC | 350,000 2.500% |
350,000 (New Position) |
Filing History |
| 2023-02-10 2:54 pm Purchase |
2022-12-31 | 13G | Murphy Canyon Acquisition Corp. MURF |
Hudson Bay Capital Management LP | 934,112 6.680% |
934,112 (New Position) |
Filing History |
| 2023-02-10 1:46 pm Purchase |
2022-12-31 | 13G | Murphy Canyon Acquisition Corp. MURF |
Polar Asset Management Partners Inc. | 700,000 5.010% |
700,000 (New Position) |
Filing History |